Home Tags Pharma
Doctors used a cutting-edge medical technique called gene therapy to treat 10 babies born with the disease. The biotech that helped saw its stock surge.
Outrage over the cost of the life-saving drug insulin has drugmakers scrambling, but Congress and the public demand a price cut
Critics call the new programs "PR stunts,"and say drug companies should just lower their prices.
Seven top pharma executives said they support the idea of lower drug prices, but had conditions before they would commit to doing so.
These powerful but little-known companies that have been blamed for high drug prices are now coming out of the shadows for a congressional interrogati...
The US has a high drug prices problem. These obscure but powerful companies will now face some tough questions on Capitol Hill.
For people with diabetes struggling to buy lifesaving insulin, a major health company is now offering the drug for just $25 a month
Insulin is a lifesaving product for individuals with diabetes. But it's also become incredibly expensive, sometimes prohibitively so for patients.
The top scientist at AveXis told us the ‘unique’ strength that powered its $9 billion sale to Novartis, and it could shape the future of g...
Manufacturing has emerged as a huge challenge for the booming gene therapy industry because these products are so new and complex.
The deal has faced growing unhappiness from shareholders, who had been hoping for a different type of acquisition.
Bill Gates is worried about gene editing worsening inequality. Now a top ethicist is raising new red flags.
New technology has made it possible to tinker with the very DNA that makes us who we are, offering fresh hope of new cures for difficult diseases.
The treatment that cured 2 men of HIV may also help with a remarkable array of more than 70 deadly diseases
Bone marrow transplants have potential in more than 70 diseases, including many cancers, but the procedure also has important limits.
Making sure people get their shots is key to improving US healthcare, the head of the FDA told us in an interview.